satavaptan

Introduction

Not yet FDA approved.

Indications

• presumably SIADH

Dosage

12.5-50 mg PO

Mechanism of action

• vasopressin V2 receptor antagonist
• increases urine volume, decreases urine osmolality

More general terms

• vasopressin receptor antagonist (vaptan)